Fatty Liver Treatment Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Fatty Liver Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Fatty Liver Treatment Market Size During the Forecast Period?
The market for fatty liver disease treatment has seen substantial growth in recent times. It is predicted to expand from a worth of $23.73 billion in 2024, reaching $25.12 billion in 2025 with a compound annual growth rate (CAGR) of 5.8%. Factors like the rise in obesity, inactive lifestyles, poor nutritional habits, a lack of sufficient treatment alternatives, and awareness programs have contributed to the growth experienced during the historic time frame.

In the coming years, substantial growth is anticipated in the fatty liver treatment market. Projected to reach $33.07 billion by 2029, it is set to record a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period is a result of increasing prevalence of the disease, surge in healthcare spending, rise in diabetes and metabolic syndrome, as well as innovative developments in therapeutics. Noteworthy trends during this period include the adoption of precision medicine techniques, lifestyle alteration programs, targeted treatments for Nash, non-invasive tracking tools, and advancements in technology.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12581

What Are the High-Growth Segments in the Fatty Liver Treatment Market?
The fatty liver treatment market covered in this report is segmented -

1) By Treatment Type: Anti-Rejection Drugs Or Immunosuppressants, Chemotherapy Drugs, Targeted Therapy, Vaccines, Anti-Viral Drugs
2) By Disease Type: Hepatitis, Liver Cancer, Non-Alcoholic Fatty Liver Disease, Other Diseases
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

Subsegments:
1) By Anti-Rejection Drugs Or Immunosuppressants: Corticosteroids, Calcineurin Inhibitors, mTOR Inhibitors
2) By Chemotherapy Drugs: Conventional Chemotherapy Agents, Novel Chemotherapeutics Under Investigation
3) By Targeted Therapy: Small Molecule Inhibitors, Monoclonal Antibodies
4) By Vaccines: Therapeutic Vaccines, Preventive Vaccines
5) By Anti-Viral Drugs: Direct-Acting Antivirals (DAAs), Nucleos(t)ide Analogs

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12581&type=smp

What Key Drivers Are Expected to Influence Future Fatty Liver Treatment Market Growth?
The surge in alcohol intake is anticipated to fuel the expansion of the fatty liver treatment market. The term "alcohol consumption" refers to the ingestion of alcoholic beverages, which contain psychoactive substances that have sedative effects on the central nervous system. Excessive drinking can intensify fatty liver disease and result in serious liver conditions, including alcoholic fatty liver disease (AFLD) and alcoholic hepatitis. For example, the HRB National Drugs Library, a government-funded organization based in Ireland, reported in March 2023, that in 2022 the per capita consumption of pure alcohol for individuals aged 15 and above in Scotland heightened to 10.2 liters which is a 7.6% jump when compared to 2021. This alarming rise in alcohol consumption took place despite continuous public health initiatives to lower intake. Consequently, this surge in alcohol usage is steering the advancement of the fatty liver treatment market.

Which Companies Hold the Largest Share Across Different Fatty Liver Treatment Market Segments?
Major companies operating in the fatty liver treatment market include Pfizer Inc., Johnson & Johnson Services Inc., Hoffmann La Roche Ltd., AstraZeneca plc, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., The Bristol-Myers Squibb Company, GlaxoSmithkline plc, Mitsubishi Chemical Holdings, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Novo Nordisk A/S, Eisai Co. Ltd., Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited, GW Pharmaceuticals Limited, Retrophin Inc., Alnylam Pharmaceuticals Inc., Intercept Pharmaceuticals Inc., AbbKine Scientific Co. Ltd., Daewoong Co. Ltd., Madrigal Pharmaceuticals Inc., Orchid Chemicals & Pharmaceuticals Limited, Genfit, NGM Biopharmaceuticals Inc., Cardax Inc., Conatus Pharmaceuticals Inc., Limerick Biopharma Inc.

What Trends Are Driving Growth in The Fatty Liver Treatment Market?
Product innovation is emerging as a significant trend in the fatty liver treatment market. Big players in the market are creating innovative products to reinforce their market standing. For example, in March 2023, Akero Therapeutics, an American biotech firm, announced favorable Phase II results for its product, efruxifermin. This is designed for the treatment of non-invasively detected nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). It is a unique Fc-FGF21 fusion protein that imitates the functional activity of fibroblast growth factor 21 (FGF21), responsible for controlling multiple metabolic pathways and cellular processes.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/fatty-liver-treatment-global-market-report

What Are the Emerging Geographies for The Fatty Liver Treatment Market Growth?
North America was the largest region in the fatty liver treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fatty liver treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Fatty Liver Treatment Market?
2. What is the CAGR expected in the Fatty Liver Treatment Market?
3. What Are the Key Innovations Transforming the Fatty Liver Treatment Industry?
4. Which Region Is Leading the Fatty Liver Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.